4/A: Artivion Inc. Executive Amends SEC Filing to Correct Share Sale Reporting Error

Amy Horton, VP and Chief Accounting Officer of Artivion Inc., files an amended Form 4 to correct the number of shares sold to cover tax withholding obligations.

Summary

• Amy Horton, VP and Chief Accounting Officer of Artivion Inc. (AORT), filed an amended Form 4 with the SEC on March 14, 2024, to correct errors in the original filing from February 28, 2024.
• The amendment addresses inaccuracies in the number of shares sold on February 26, 2024, to cover tax withholding obligations related to the vesting of performance stock units.
• The original Form 4 incorrectly reported the sale of 1,186 shares and 980 shares in two separate transactions, while the corrected numbers are 1,168 and 966 shares, respectively.
• As a result of these corrections, the number of shares beneficially owned by Horton has been adjusted to reflect the accurate sales figures.
• The transactions involved the acquisition of 3,366 and 6,418 shares of common stock on February 23, 2024, related to performance stock units granted on February 22, 2023.
• The sales were executed to satisfy tax withholding obligations via 'sell to cover' transactions and are not considered discretionary.
• The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

Sentiment

Score: 7

Explanation: The sentiment is neutral. The document is a routine correction of a previous filing. While the initial error is a slight negative, the correction demonstrates transparency.

Positives

• The amendment indicates transparency and a commitment to accurate reporting by the executive.
• The 'sell to cover' transaction ensures tax obligations are met without requiring discretionary sales.

Negatives

• The need for an amendment suggests an initial oversight in reporting the share sales.

Risks

• While the amendment corrects a minor error, repeated inaccuracies in SEC filings could raise concerns about internal controls.

Future Outlook

The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding insider transactions.

Stakeholder Impact

• The correction of the filing ensures accurate information is available to shareholders and potential investors.

Key Dates